Enzyme Kinetics and Interaction Studies for Human JNK1β1 and Substrates Activating Transcription Factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun)

Documenti analoghi

• Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation
  di: Chambers, Jeremy W., et al.
  Pubblicazione: (2011)
• Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) Inhibitors
  di: Zheng, Ke, et al.
  Pubblicazione: (2015)
• Blocking c-Jun N-terminal Kinase (JNK) Translocation to the Mitochondria Prevents 6-Hydroxydopamine-induced Toxicity in Vitro and in Vivo
  di: Chambers, Jeremy W., et al.
  Pubblicazione: (2013)
• Synthesis, Biological Evaluation, X-Ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors
  di: Kamenecka, Ted, et al.
  Pubblicazione: (2010)
• Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
  di: Shin, Youseung, et al.
  Pubblicazione: (2009)